Cargando…
Lung microbiome in children with hematological malignancies and lower respiratory tract infections
BACKGROUND: Respiratory infectious complications remain a major cause of morbidity and mortality in children with hematological malignancies. Knowledge regarding the lung microbiome in aforementioned children is limited. METHODS: A prospective cohort was conducted, enrolling 16 children with hematol...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533145/ https://www.ncbi.nlm.nih.gov/pubmed/36212487 http://dx.doi.org/10.3389/fonc.2022.932709 |
_version_ | 1784802281266348032 |
---|---|
author | Zhang, Yun Ning, Haonan Zheng, Wenyu Liu, Jing Li, Fuhai Chen, Junfei |
author_facet | Zhang, Yun Ning, Haonan Zheng, Wenyu Liu, Jing Li, Fuhai Chen, Junfei |
author_sort | Zhang, Yun |
collection | PubMed |
description | BACKGROUND: Respiratory infectious complications remain a major cause of morbidity and mortality in children with hematological malignancies. Knowledge regarding the lung microbiome in aforementioned children is limited. METHODS: A prospective cohort was conducted, enrolling 16 children with hematological malignancies complicated with moderate-to-severe lower respiratory tract infections (LRTIs) versus 21 LRTI children with age, gender, weight, and infection severity matched, with no underlying malignancies, to evaluate the lung microbiome from bronchoalveolar lavage fluid samples in different groups. RESULTS: The lung microbiome from children with hematological malignancies and LRTIs showed obviously decreased α and β diversity; increased microbial function in infectious disease:bacteria/parasite; drug resistance:antimicrobial and human pathogenesis than the control group; a significantly reduced proportion of Firmicutes, Bacteroidota, Actinobacteriota; increased Proteobacteria at the phylum level; and distinctly elevated Parabacteroides, Klebsiella, Grimontia, Escherichia_Shigella, unclassified_Enterobacteriaceae at the genus level than the control group. Furthermore, it was revealed that α diversity (Shannon), β diversity (Bray–Curtis dissimilarity), Proteobacteria at the phylum level, and unclassified_Enterobacteriaceae and Escherichia_Shigella at the genus level were significantly negatively associated with hospitalization course whereas Firmicutes at the phylum level was established positively correlated with the hospitalization course. CONCLUSIONS: Children with hematological malignancies and LRTIs showed obviously decreased α and β diversity, significantly increased function in infectious disease pathogenesis, antimicrobial drug resistance, and unfavorable environment tolerance. Moreover, α diversity (Shannon), β diversity (Bray–Curtis dissimilarity), and Proteobacteria may be used as negative correlated predictors for hospitalization course in these children whereas Firmicutes may be utilized as a positive correlated predictor. |
format | Online Article Text |
id | pubmed-9533145 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95331452022-10-06 Lung microbiome in children with hematological malignancies and lower respiratory tract infections Zhang, Yun Ning, Haonan Zheng, Wenyu Liu, Jing Li, Fuhai Chen, Junfei Front Oncol Oncology BACKGROUND: Respiratory infectious complications remain a major cause of morbidity and mortality in children with hematological malignancies. Knowledge regarding the lung microbiome in aforementioned children is limited. METHODS: A prospective cohort was conducted, enrolling 16 children with hematological malignancies complicated with moderate-to-severe lower respiratory tract infections (LRTIs) versus 21 LRTI children with age, gender, weight, and infection severity matched, with no underlying malignancies, to evaluate the lung microbiome from bronchoalveolar lavage fluid samples in different groups. RESULTS: The lung microbiome from children with hematological malignancies and LRTIs showed obviously decreased α and β diversity; increased microbial function in infectious disease:bacteria/parasite; drug resistance:antimicrobial and human pathogenesis than the control group; a significantly reduced proportion of Firmicutes, Bacteroidota, Actinobacteriota; increased Proteobacteria at the phylum level; and distinctly elevated Parabacteroides, Klebsiella, Grimontia, Escherichia_Shigella, unclassified_Enterobacteriaceae at the genus level than the control group. Furthermore, it was revealed that α diversity (Shannon), β diversity (Bray–Curtis dissimilarity), Proteobacteria at the phylum level, and unclassified_Enterobacteriaceae and Escherichia_Shigella at the genus level were significantly negatively associated with hospitalization course whereas Firmicutes at the phylum level was established positively correlated with the hospitalization course. CONCLUSIONS: Children with hematological malignancies and LRTIs showed obviously decreased α and β diversity, significantly increased function in infectious disease pathogenesis, antimicrobial drug resistance, and unfavorable environment tolerance. Moreover, α diversity (Shannon), β diversity (Bray–Curtis dissimilarity), and Proteobacteria may be used as negative correlated predictors for hospitalization course in these children whereas Firmicutes may be utilized as a positive correlated predictor. Frontiers Media S.A. 2022-09-21 /pmc/articles/PMC9533145/ /pubmed/36212487 http://dx.doi.org/10.3389/fonc.2022.932709 Text en Copyright © 2022 Zhang, Ning, Zheng, Liu, Li and Chen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Zhang, Yun Ning, Haonan Zheng, Wenyu Liu, Jing Li, Fuhai Chen, Junfei Lung microbiome in children with hematological malignancies and lower respiratory tract infections |
title | Lung microbiome in children with hematological malignancies and lower respiratory tract infections |
title_full | Lung microbiome in children with hematological malignancies and lower respiratory tract infections |
title_fullStr | Lung microbiome in children with hematological malignancies and lower respiratory tract infections |
title_full_unstemmed | Lung microbiome in children with hematological malignancies and lower respiratory tract infections |
title_short | Lung microbiome in children with hematological malignancies and lower respiratory tract infections |
title_sort | lung microbiome in children with hematological malignancies and lower respiratory tract infections |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533145/ https://www.ncbi.nlm.nih.gov/pubmed/36212487 http://dx.doi.org/10.3389/fonc.2022.932709 |
work_keys_str_mv | AT zhangyun lungmicrobiomeinchildrenwithhematologicalmalignanciesandlowerrespiratorytractinfections AT ninghaonan lungmicrobiomeinchildrenwithhematologicalmalignanciesandlowerrespiratorytractinfections AT zhengwenyu lungmicrobiomeinchildrenwithhematologicalmalignanciesandlowerrespiratorytractinfections AT liujing lungmicrobiomeinchildrenwithhematologicalmalignanciesandlowerrespiratorytractinfections AT lifuhai lungmicrobiomeinchildrenwithhematologicalmalignanciesandlowerrespiratorytractinfections AT chenjunfei lungmicrobiomeinchildrenwithhematologicalmalignanciesandlowerrespiratorytractinfections |